Your email has been successfully added to our mailing list.

×
0 0 -0.0190476190476191 -0.00952380952380953 -0.00952380952380953 0 0.0190476190476191 0.00952380952380953
Stock impact report

Justifiable Lack Of Excitement [Seeking Alpha]

SELLAS Life Sciences Group, Inc. (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
Company Research Source: Seeking Alpha
Summary Investment Thesis The company is undercapitalized. There is no way for the company to bring their products to approval and production without further massive dilution of the shareholders. Even under optimistic scenarios, the revenues are still many years away. The market is not excited about the products and the stock. That is likely to continue. Every significant rally in the stock should be sold. Brief Overview SELLAS Life Sciences focuses on the development of immunotherapies for a range of cancers. The lead product, GALINPEPIMUT-S, is about to enter phase 3 clinical trials for patients with Acute Myeloid Leukemia ( AML ) and Malignant Plural Mesothelioma ( MPM ). Another product, NEUVAX™ (NELIPEPIMUT-S), is undergoing phase 2 clinical studies in combination with TRASTUZUMAB for certain types of breast cancer patients. An update on the study will be presented in October 2018 at an upcoming European Society for Medical Oncology meeting. Other products (GA Show less Read more
Impact Snapshot
Event Time:
SLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SLS alerts

from News Quantified
Opt-in for
SLS alerts

from News Quantified